Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC. | 41,800 | reported | 20 May 2026 | tx 39+379,183−83,583 |
| Zymeworks Inc. | 25,000 | reported | 21 Dec 2022 | tx 1+25,000 |
| enGene Holdings Inc. | 22,500 | reported | 16 Jun 2025 | tx 3+82,500 |
| Zymeworks Inc. | 9,000 | reported | 06 May 2021 | tx 3+28,000 |
| Orexigen Therapeutics, Inc. | 5,000 | reported | 14 Jul 2017 | tx 7+155,000−70,000 |
| FIRST FINANCIAL BANKSHARES INC | 2,142 | reported | 28 Apr 2026 | tx 1+2,142 |
| HYPERION THERAPEUTICS INC | 0 | reported | 07 May 2015 | tx 9+22,186−38,201 |
| NEWLINK GENETICS CORP | 0 | reported | 12 Dec 2024 | tx 47+212,856−149,253 |
| 89bio, Inc. | 0 | reported | 30 Oct 2025 | tx 12+186,450−186,450 |
| Spark Therapeutics, Inc. | 0 | reported | 17 Dec 2019 | tx 15+32,000−32,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 May 2026 | GRANT_AWARD | INOVIO PHARMACEUTICALS, INC. | 41,800 | 0.00 USD | deriv |
| 20 May 2026 | GRANT_AWARD | INOVIO PHARMACEUTICALS, INC. | 34,200 | 0.00 USD | deriv |
| 28 Apr 2026 | GRANT_AWARD | FIRST FINANCIAL BANKSHARES INC | 2,142 | 0.00 USD | |
| 30 Oct 2025 | OTHER | 89bio, Inc. | 20,000 | 0.00 USD | deriv |
| 30 Oct 2025 | OTHER | 89bio, Inc. | 12,500 | 0.00 USD | deriv |
| 30 Oct 2025 | OTHER | 89bio, Inc. | 25,000 | 0.00 USD | deriv |
| 30 Oct 2025 | OTHER | 89bio, Inc. | 27,400 | 0.00 USD | deriv |
| 30 Oct 2025 | OTHER | 89bio, Inc. | 45,150 | 0.00 USD | deriv |
| 30 Oct 2025 | OTHER | 89bio, Inc. | 56,400 | 0.00 USD | deriv |
| 16 Jun 2025 | GRANT_AWARD | enGene Holdings Inc. | 22,500 | 0.00 USD | deriv |
| 21 May 2025 | EXERCISE | INOVIO PHARMACEUTICALS, INC. | 2,167 | — | |
| 21 May 2025 | EXERCISE | INOVIO PHARMACEUTICALS, INC. | 2,167 | 0.00 USD | deriv |
| 03 Feb 2025 | GRANT_AWARD | 89bio, Inc. | 56,400 | 0.00 USD | deriv |
| 12 Dec 2024 | OTHER | NEWLINK GENETICS CORP | 2,187 | — | |
| 12 Dec 2024 | OTHER | NEWLINK GENETICS CORP | 5,324 | — | deriv |
| 12 Dec 2024 | OTHER | NEWLINK GENETICS CORP | 2,777 | — | deriv |
| 12 Dec 2024 | OTHER | NEWLINK GENETICS CORP | 2,910 | — | deriv |
| 12 Dec 2024 | OTHER | NEWLINK GENETICS CORP | 3,431 | — | deriv |
| 12 Dec 2024 | OTHER | NEWLINK GENETICS CORP | 5,684 | — | deriv |
| 12 Dec 2024 | OTHER | NEWLINK GENETICS CORP | 3,345 | — | deriv |
| 12 Dec 2024 | OTHER | NEWLINK GENETICS CORP | 3,328 | — | deriv |
| 15 Jun 2024 | GRANT_AWARD | enGene Holdings Inc. | 20,000 | 0.00 USD | deriv |
| 05 Jun 2024 | GRANT_AWARD | NEWLINK GENETICS CORP | 3,328 | 0.00 USD | deriv |
| 21 May 2024 | GRANT_AWARD | INOVIO PHARMACEUTICALS, INC. | 2,167 | 0.00 USD | deriv |
| 21 May 2024 | GRANT_AWARD | INOVIO PHARMACEUTICALS, INC. | 2,917 | 0.00 USD | deriv |